This has been observed in studies of sleep-deprived mice with Alzheimer’s disease, which showed altered levels of BMAL1 protein, as well as in patients with Parkinson’s disease, in whom relative BMAL1 levels positively correlate with disease severity [24,25]. This evidence concerns the gene BMAL1 and Alzheimer disease.